BRIEF published on 05/17/2024 at 18:05, 1 year 6 months ago COFIDUR Announces the Rectification of Purchases of Own Shares 2024 Correction COFIDUR Purchases Of Own Shares
BRIEF published on 05/15/2024 at 18:05, 1 year 6 months ago Attendance sheet for the COFIDUR Mixed General Meeting scheduled for May 2024 Shareholders Business Management Combined General Meeting COFIDUR May 15, 2024
BRIEF published on 05/10/2024 at 18:05, 1 year 6 months ago Declaration of Purchases of Own Shares by COFIDUR as of May 3, 2024 Press Release Stock Transactions COFIDUR Purchases Of Own Shares May 3, 2024
BRIEF published on 05/03/2024 at 18:05, 1 year 7 months ago Declaration of purchase of own shares by COFIDUR as of April 26, 2024 Own Shares Financial Strategy Purchase Of Shares COFIDUR April 26, 2024
BRIEF published on 04/24/2024 at 18:05, 1 year 7 months ago Convocation to the COFIDUR General Assembly scheduled for May 15, 2024 Shareholders General Assembly Vote COFIDUR May 15, 2024
Published on 12/05/2025 at 02:35, 4 hours 29 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 4 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 59 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 4 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 33 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 13 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 38 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 49 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 53 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 13 hours 4 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 19 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 19 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
